PERINDOPRIL ERBUMINE (perindopril erbumine) by Aurobindo Pharma is pro-drug for perindoprilat, which inhibits ace in human subjects and animals. Approved for nonfatal myocardial infarction. First approved in 2009.
Drug data last refreshed 18h ago
pro-drug for perindoprilat, which inhibits ACE in human subjects and animals. The mechanism through which perindoprilat lowers blood pressure is believed to be primarily inhibition of ACE activity. ACE is a peptidyl dipeptidase that catalyzes conversion of the inactive decapeptide, angiotensin I,…
Worked on PERINDOPRIL ERBUMINE at Aurobindo Pharma? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.